Status:
COMPLETED
Patient Activation Through Counseling, Exercise and Mobilization
Lead Sponsor:
Herlev and Gentofte Hospital
Collaborating Sponsors:
Rigshospitalet, Denmark
University of Copenhagen
Conditions:
Pancreas Cancer
Biliary Tract Cancer
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
PACE-Mobil-PBL is a prospective randomized controlled trial. The aim is to investigate the effect of a multimodal and exercise-based intervention among older patients with advanced pancreatic cancer, ...
Eligibility Criteria
Inclusion
- Inclusion Criteria, participants must:
- Be diagnosed with locally advanced or metastatic pancreatic cancer, OR locally advanced or metastatic biliary tract cancer, OR locally advanced or metastatic non-small cell lung cancer within 12 weeks.
- Have unresectable cancer.
- Be treated with first-line palliative chemotherapy, immunotherapy or targeted therapy at the Department of Oncology, Herlev and Gentofte Hospital.
- Have an Eastern Cooperative Oncology Group (ECOG) performance status ≤2.
- Have the ability to speak and read Danish, and to provide a signed informed consent form.
- Exclusion Criteria, patients with:
- Small-cell lung cancer.
- Any physical condition that hinder the execution of physical exercise training.
- Documented and uncontrolled brain metastases that hinder participation in an exercise-based trial, based on the referring oncologist's assessment.
- Dementia, psychotic disorders, or other cognitive diseases or conditions that hinder participation in a clinical exercise-based trial.
- Unstable medical disease or history of serious or concurrent illness; any Medical condition that might be aggravated by exercise training or that cannot be controlled, including, but not restricted to congestive heart failure (NYHA class II-IV), unstable angina pectoris, implantable cardioverter defibrillator, or myocardial infarction within 6 months, based on the referring oncologist's assessment.
- In patients with bone metastases:
- \- A bone metastatic burden or location that poses a risk of injury in the performance of exercise training, as assessed by the referring oncologist.
Exclusion
Key Trial Info
Start Date :
April 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT03411200
Start Date
April 4 2018
End Date
July 1 2020
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev and Gentofte Hospital, Department of Oncology
Herlev, Denmark, 2730